13,912 Shares in Chemed Corporation (NYSE:CHE) Purchased by Harel Insurance Investments & Financial Services Ltd.

Harel Insurance Investments & Financial Services Ltd. purchased a new stake in Chemed Corporation (NYSE:CHE - Free Report) in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 13,912 shares of the company's stock, valued at approximately $8,560,000. Harel Insurance Investments & Financial Services Ltd. owned about 0.10% of Chemed as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently bought and sold shares of the company. Whipplewood Advisors LLC increased its holdings in shares of Chemed by 54.5% in the 1st quarter. Whipplewood Advisors LLC now owns 51 shares of the company's stock valued at $31,000 after acquiring an additional 18 shares during the last quarter. Impact Capital Partners LLC increased its stake in Chemed by 2.7% during the first quarter. Impact Capital Partners LLC now owns 763 shares of the company's stock valued at $469,000 after purchasing an additional 20 shares during the last quarter. CBIZ Investment Advisory Services LLC raised its holdings in shares of Chemed by 64.7% during the fourth quarter. CBIZ Investment Advisory Services LLC now owns 56 shares of the company's stock worth $30,000 after purchasing an additional 22 shares during the period. CIBC Private Wealth Group LLC lifted its position in shares of Chemed by 13.5% in the 4th quarter. CIBC Private Wealth Group LLC now owns 185 shares of the company's stock worth $98,000 after buying an additional 22 shares during the last quarter. Finally, KFG Wealth Management LLC lifted its position in shares of Chemed by 4.6% in the 1st quarter. KFG Wealth Management LLC now owns 525 shares of the company's stock worth $323,000 after buying an additional 23 shares during the last quarter. Institutional investors and hedge funds own 95.85% of the company's stock.

Chemed Stock Up 0.3%

Shares of NYSE:CHE opened at $472.61 on Friday. The company's 50-day moving average price is $557.22 and its 200 day moving average price is $562.94. The company has a market cap of $6.91 billion, a PE ratio of 23.02, a P/E/G ratio of 2.27 and a beta of 0.50. Chemed Corporation has a fifty-two week low of $469.80 and a fifty-two week high of $623.61.

Chemed (NYSE:CHE - Get Free Report) last announced its quarterly earnings results on Wednesday, April 23rd. The company reported $5.63 EPS for the quarter, beating the consensus estimate of $5.59 by $0.04. Chemed had a net margin of 12.40% and a return on equity of 27.58%. The company had revenue of $646.94 million for the quarter, compared to analyst estimates of $641.78 million. During the same quarter last year, the business earned $5.20 earnings per share. Chemed's revenue was up 9.8% compared to the same quarter last year. As a group, equities analysts anticipate that Chemed Corporation will post 21.43 EPS for the current year.

Chemed Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, June 17th. Investors of record on Thursday, May 29th were given a $0.50 dividend. The ex-dividend date was Thursday, May 29th. This represents a $2.00 dividend on an annualized basis and a yield of 0.42%. Chemed's dividend payout ratio is presently 9.74%.

Insider Transactions at Chemed

In other news, CEO Kevin J. Mcnamara sold 1,500 shares of the business's stock in a transaction on Monday, May 5th. The stock was sold at an average price of $576.45, for a total value of $864,675.00. Following the sale, the chief executive officer owned 101,197 shares of the company's stock, valued at approximately $58,335,010.65. The trade was a 1.46% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Spencer S. Lee sold 1,500 shares of the firm's stock in a transaction dated Friday, May 16th. The shares were sold at an average price of $577.99, for a total value of $866,985.00. Following the transaction, the executive vice president directly owned 14,627 shares of the company's stock, valued at $8,454,259.73. This represents a 9.30% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 4,500 shares of company stock valued at $2,598,450 in the last quarter. 3.29% of the stock is currently owned by insiders.

Analysts Set New Price Targets

CHE has been the topic of a number of recent research reports. Wall Street Zen raised shares of Chemed from a "hold" rating to a "buy" rating in a report on Friday, March 7th. Royal Bank Of Canada reissued an "outperform" rating and issued a $640.00 price target (down previously from $674.00) on shares of Chemed in a report on Monday. Finally, Bank of America reduced their price objective on Chemed from $708.00 to $650.00 and set a "buy" rating for the company in a research report on Monday.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Corporation (NYSE:CHE - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.